Results 301 to 310 of about 2,051,186 (321)

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

The Lancet Oncology, 2019
BACKGROUND Patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations have poor prognosis. We aimed to establish the efficacy of ramucirumab in patients with advanced hepatocellular carcinoma and α-fetoprotein ...
A. Zhu, Yoon-Koo Kang, C. Yen, R. Finn, P. Galle, J. Llovet, E. Assenat, G. Brandi, M. Pracht, Ho Yeong Lim, K. Rau, K. Motomura, I. Ohno, P. Merle, B. Daniele, D. Shin, G. Gerken, C. Borg, J. Hiriart, T. Okusaka, M. Morimoto, Y. Hsu, P. Abada, M. Kudo   +23 more
semanticscholar   +1 more source

Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma

Nature Metabolism, 2023
Zijian Yang, Cong Yan, Jiaqiang Ma, Panpan Peng, Xuelian Ren, S. Cai, Xia Shen, Yingcheng Wu, Shu Zhang, Xiaoying Wang, S. Qiu, Jian Zhou, Jia Fan, He Huang, Qiang Gao   +14 more
semanticscholar   +1 more source

Hepatocellular Carcinoma: New Developments.

Clinical Liver Disease, 2023
Previn Ganesan, L. Kulik
semanticscholar   +1 more source

Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers.

Cancer metastasis reviews, 2023
Yu Wang, Baocheng Deng
semanticscholar   +1 more source

Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma

Nature Medicine, 2022
A. Zhu, Alexander R. Abbas, Marina Ruiz de Galarreta, Y. Guan, Shan Lu, H. Koeppen, Wenjun Zhang, Chih-Hung Hsu, A. He, B. Ryoo, T. Yau, A. Kaseb, Adam M. Burgoyne, F. Dayyani, J. Spahn, W. Verret, R. Finn, H. Toh, A. Lujambio, Yulei N. Wang   +19 more
semanticscholar   +1 more source

Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma

Cell, 2021
Yun-Fan Sun, Liang Wu, Yu Zhong
exaly  

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.

The Lancet Oncology, 2009
A. Cheng, Yoon-Koo Kang, Zhendong Chen, C. Tsao, S. Qin, Jun Suk Kim, R. Luo, Jifeng Feng, S. Ye, Tsai‐Sheng Yang, Jianming Xu, Yan Sun, Houjie Liang, Jiwei Liu, Jie-jun Wang, W. Tak, H. Pan, K. Burock, J. Zou, D. Voliotis, Z. Guan   +20 more
semanticscholar   +1 more source

Hepatocellular Carcinoma

New England Journal of Medicine, 2011
openaire   +2 more sources

Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma

Ca-A Cancer Journal for Clinicians, 2012
Mary Maluccio, Anne Covey
exaly  

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

Gastroenterology, 2007
H. El‐Serag, K. Rudolph
semanticscholar   +1 more source